Sign in

CIK 0001701108 · Non-accelerated filer<br>Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
  1. 4 Grant or award Director acquired 20,000 shares (grant or award)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Grant or award Director acquired 20,000 shares (grant or award)
  4. 4 Grant or award Director acquired 20,000 shares (grant or award)
  5. 4 Grant or award Director acquired 20,000 shares (grant or award)
  6. 4 Grant or award Director acquired 20,000 shares (grant or award)
  7. 4 Open-market sale Chief Operating Officer sold 30,971 shares at $1.36 ($42,121)
  8. 4 Open-market sale Director sold 63,795 shares at $1.37 ($87,399)
  9. 4 Open-market sale Chief Legal Officer sold 30,906 shares at $1.37 ($42,341)
  10. 4 Open-market sale Chief Medical Officer sold 28,075 shares at $1.37 ($38,463)
  11. 4 Grant or award See Remarks acquired 119,866 shares (grant or award)
  12. 4 Planned sale CEO and President sold 75,994 shares at an average $1.42 ($107,719)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award See Remarks acquired 300,000 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award Director acquired 20,000 shares (grant or award)
  17. 4 Grant or award Director acquired 20,000 shares (grant or award)
  18. 4 Grant or award Director acquired 20,000 shares (grant or award)
  19. 4 Grant or award Director acquired 20,000 shares (grant or award)
  20. 4 Grant or award Director acquired 20,000 shares (grant or award)

Page 3 of 12 · 231 filings